Stocks · News reference
Genprex shares are trading lower. The company announced its collaboration with Roche Diagnostics to validate biomarkers for patient selection in clinical trials for non-small cell lung cancer.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 3, 2026, 2:29 PM
- Checked
- Aug 3, 2026, 2:29 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Genprex, Inc. (GNPX)
Filed: 2026-08-18 AccNo: 0001437749-26-028250 Size: 171 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgar12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.
Read original at benzinga